Apollo Endosurgery Inc (APEN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Apollo Endosurgery Inc (APEN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7363
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Apollo Endosurgery Inc (Apollo Endo), formerly Lpath Inc, is a medical technology company that designs, develops and commercializes medical devices used for the treatment of obesity. The company’s product portfolio comprises endo-bariatric products such as Orbera Intragastric Balloon System and OverStitch endoscopic suturing system; and Lap-Band system for laparoscopic bariatric surgeries. These surgical and non-surgical interventional devices are also used in procedures that address or repair a variety of gastrointestinal defects. Apollo Endo’s products are used by bariatric surgeons, general surgeons and gastroenterologists. It has a manufacturing facility in the Coyol Free Trade Zone in Alajuela, Costa Rica. Apollo Endo is headquartered in Austin, Texas, the US.

Apollo Endosurgery Inc (APEN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Apollo Endosurgery Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Apollo Endosurgery Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Apollo Endosurgery Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Apollo Endosurgery Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Apollo Endosurgery Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Apollo Endosurgery Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 10
Venture Financing 12
Apollo Endosurgery Secures USD50 Million from Athyrium Opportunities Fund 12
Apollo Endosurgery Raises US$60.7 Million In Series C Financing 13
Apollo Endosurgery Raises US$47.6 Million In New Round Of Financing 14
Partnerships 15
Lpath Enters Into Licensing Agreement With Provista Diagnostics For Cancer Diagnostics 15
Apollo Endosurgery Enters into Distribution Agreement with Slater Endoscopy 16
Merger 17
Lpath and Apollo Endosurgery Merges 17
Equity Offering 18
Apollo Endosurgery Raises USD23.7 Million in Public Offering of Shares 18
Apollo Endosurgery to Raise up to USD16 Million in Public Offering of Shares 20
Apollo Endosurgery Raises USD36 Million in Public Offering of Shares 21
Apollo Endosurgery Inc – Key Competitors 23
Apollo Endosurgery Inc – Key Employees 24
Apollo Endosurgery Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 08, 2018: Apollo Endosurgery reports second quarter 2018 results 26
May 03, 2018: Apollo Endosurgery Reports First Quarter 2018 Results 27
Mar 01, 2018: Apollo Endosurgery Reports Fourth Quarter and Full Year 2017 Results 28
Oct 26, 2017: Apollo Endosurgery Reports Third Quarter 2017 Results 30
Aug 01, 2017: Apollo Endosurgery Reports Second Quarter 2017 Results 32
Jul 12, 2017: Apollo Endosurgery Reports Preliminary Unaudited Financial Estimates for the Second Quarter of 2017 34
May 04, 2017: Apollo Endosurgery Reports First Quarter 2017 Results 35
Mar 08, 2017: Apollo Endosurgery Reports Fourth Quarter and Full Year 2016 Results 36
Corporate Communications 38
May 31, 2018: Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors 38
Jan 17, 2017: Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Apollo Endosurgery Inc, Medical Equipment, Key Facts, 2017 2
Apollo Endosurgery Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Apollo Endosurgery Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Apollo Endosurgery Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Apollo Endosurgery Inc, Deals By Market, 2012 to YTD 2018 8
Apollo Endosurgery Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 10
Apollo Endosurgery Secures USD50 Million from Athyrium Opportunities Fund 12
Apollo Endosurgery Raises US$60.7 Million In Series C Financing 13
Apollo Endosurgery Raises US$47.6 Million In New Round Of Financing 14
Lpath Enters Into Licensing Agreement With Provista Diagnostics For Cancer Diagnostics 15
Apollo Endosurgery Enters into Distribution Agreement with Slater Endoscopy 16
Lpath and Apollo Endosurgery Merges 17
Apollo Endosurgery Raises USD23.7 Million in Public Offering of Shares 18
Apollo Endosurgery to Raise up to USD16 Million in Public Offering of Shares 20
Apollo Endosurgery Raises USD36 Million in Public Offering of Shares 21
Apollo Endosurgery Inc, Key Competitors 23
Apollo Endosurgery Inc, Key Employees 24
Apollo Endosurgery Inc, Other Locations 25
Apollo Endosurgery Inc, Subsidiaries 25

List of Figures
Apollo Endosurgery Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Apollo Endosurgery Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Apollo Endosurgery Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Apollo Endosurgery Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Apollo Endosurgery Inc (APEN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nuclear Power Corporation of India Ltd-エネルギー分野:企業M&A・提携分析
    Summary Nuclear Power Corporation of India Ltd (NPCIL) designs, constructs, commissions and operates nuclear power reactors. It is controlled and governed by the Department of Atomic Energy (DAE), Government of India. The company generates power from nuclear with pressurized heavy water reactor, lig …
  • CNP Cyprialife Ltd:企業の戦略的SWOT分析
    CNP Cyprialife Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • U.S. Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    U.S. Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary U.S. Energy Corp (US Energy) is an oil and gas company that offers exploration, development and production of oil and natural gas properties. The company provides maintenance of mineral properties. It o …
  • RayBiotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary RayBiotech Inc (RayBiotech) is a life science company that provides proteins, antibodies and immunological kits. The company's product categories include antibody arrays, glycobiology arrays, protein arrays, phosphorylation arrays, elisa, functional assays, antibodies and custom recombinant …
  • Bio Techne Corp (TECH)-医療機器分野:企業M&A・提携分析
    Summary Bio Techne Corp (Bio Techne), develops manufactures and sells biotechnology products and instruments for research and clinical diagnostics. The company provides proteins and antibodies, and related immunoassays and other reagents for research under brands such as R&D Systems, Novus, Biologic …
  • Energy Resources Conservation and Development Commission:企業の戦略的SWOT分析
    Energy Resources Conservation and Development Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key …
  • Air Lease Corporation:企業の戦略・SWOT・財務情報
    Air Lease Corporation - Strategy, SWOT and Corporate Finance Report Summary Air Lease Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • TechnoPhage SA-製薬・医療分野:企業M&A・提携分析
    Summary TechnoPhage SA (TechnoPhage) is a biotechnology company that concentrates on research and development of new molecules. The company conducts research and development of new products based on unique properties of bacteriophages. It also conducts contract research and development services for …
  • Troy Resources Limited:企業の戦略・SWOT・財務情報
    Troy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Troy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mednax Inc (MD):医療機器:M&Aディール及び事業提携情報
    Summary Mednax Inc (Mednax) is a national medical group company, which operates a network of physician service providers. The company offers a wide range of neonatal, anesthesia, maternal-fetal, pediatric physician and subspecialty services. Its network includes other pediatric subspecialists compri …
  • Eco (Atlantic) Oil & Gas Ltd (EOG):企業の財務・戦略的SWOT分析
    Summary Eco (Atlantic) Oil & Gas Ltd (Eco) is an oil and gas exploration and development company. The company’s business activities include acquisition, identification, and development of upstream petroleum projects across Africa. The company's projects include cooper license-PEL 030, Sharon license …
  • St. George’s University of London-製薬・医療分野:企業M&A・提携分析
    Summary St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider that offers undergraduate and post graduate courses. The university’s undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthc …
  • HDI-Global SE:企業の戦略・SWOT・財務情報
    HDI-Global SE - Strategy, SWOT and Corporate Finance Report Summary HDI-Global SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ampio Pharmaceuticals Inc (AMPE):製薬・医療:M&Aディール及び事業提携情報
    Summary Ampio Pharmaceuticals Inc (Ampio), formerly Chay Enterprises Inc is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company develops compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by …
  • Novolex Holdings, Inc.:企業の戦略的SWOT分析
    Novolex Holdings, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NIBC Bank NV:電力:M&Aディール及び事業提携情報
    Summary NIBC Bank NV (NIBC), a subsidiary of NIBC Holding NV, is an enterprising bank that provides a range of corporate and consumer banking services. The company specializes in mergers and acquisitions, debt and equity mezzanine, capitalization advisory, leveraged finance and structured finance, a …
  • Paranta Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Paranta Biosciences Ltd (Paranta Biosciences) is a biopharmaceutical company that develops bio-therapeutics for the treatment of inflammatory and fibrotic diseases. The company develops product candidate PB01, a recombinant human follistatin-288 used for the treatment of cystic fibrosis lung …
  • Akorn Inc (AKRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Akorn Inc (Akorn) develops, manufactures, and commercializes generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its products in both sterile and non-sterile dosage forms including or …
  • National Health Research Institutes:製薬・医療:M&Aディール及び事業提携情報
    Summary National Health Research Institutes (NHRI) is a non-profit foundation that performs medical research programs. The foundation investigates various aspects of basic biomedical sciences and diseases including aging, cancer, infectious diseases, mental disorders and occupational diseases. It co …
  • Sharps Compliance Corp (SMED):企業の財務・戦略的SWOT分析
    Summary Sharps Compliance Corp (Sharps) is a healthcare waste solution company that offers regulatory compliant services. The company offers products such as sharps disposal systems, public sharps safety, takeaway medication recovery system, collection and disposal system, complete needle collection …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆